Business Wire

ASC

Share
Peking University and the Chinese University of Hong Kong Triumph at 10th ASC Finals, Claiming Top Prizes

The 10th ASC Student Supercomputer Challenge (ASC) Finals recently concluded at the University of Science and Technology of China (USTC) in Hefei. For the onsite competition, Peking University emerged as the overall Champion, while USTC secured the Silver Prize and e Prize, marking a remarkable achievement. Zhejiang University was honored with the Highest LINPACK award, alongside several other teams who garnered prestigious honors. In the virtual competition, the team from the Chinese University of Hong Kong emerged as the champion, while the teams from the Chinese University of Hong Kong, National Tsing Hua University, and Kasetsart University were recognized with the Application Innovation Award.

Over 300 teams from universities worldwide participated in the 10th ASC Student Supercomputer Challenge. Following the preliminary contests, the Top 24 teams advanced to the finals. Among them, the Top 20 teams from the Chinese mainland competed onsite, while others engaged in virtual participation through the AWS cloud computing platform.

During the finals, teams showcased their prowess by designing and constructing cluster systems with a maximum power consumption of 3,000 W. Furthermore, they were tasked with running and optimizing cutting-edge scientific and engineering applications, such as HPL and HPCG benchmarks, Large Language Model, DeePMD, WRF-Hydro, and FVCOM. Remarkably, the 10th ASC featured a group competition, with 24 teams divided into 4 groups, tackling the current application of random quantum circuit sampling simulation.

The competition reached its pinnacle with Peking University ultimately clinching the coveted Champion title. The team demonstrated exceptional performance across various tasks, including WRF-Hydro and DeePMD, showcasing profound expertise in comprehensive supercomputing systems, applications, and outstanding optimization abilities. Meanwhile, the USTC team secured the Silver Prize, excelling in tasks such as Large Language Model and HPL&HPCG benchmarks.

USTC's team delivered outstanding results in the challenging Large Language Model task, employing cutting-edge large model parallel strategies, computing acceleration algorithms, and video memory optimization techniques. Their considerations of training speed and loss-convergence led to the team's remarkable performance, earning them the esteemed e Prize.

Zhejiang University's team, operating within the specified 3,000W power consumption limit, attained an impressive floating-point performance of 109 TFLOPs, ultimately securing them the Highest LINPACK award.

A collaborative effort by the Southern University of Science and Technology, Lanzhou University, Shanghai Jiao Tong University, Qilu University of Technology, and the Chinese University of Hong Kong resulted in efficient optimization of random quantum circuit sampling simulation. Their commendable efforts were rewarded with the Group Competition Award.

Furthermore, Qinghai University's outstanding performance earned them the Application Innovation Award.

Jack Dongarra, Member of US National Academy of Engineering, winner of the Turing Award, Distinguished Professor at the Oak Ridge National Laboratory and the University of Tennessee, and ASC Advisory Committee Chair said in the 10th ASC Student Supercomputer Challenge Finals’ closing ceremony, "The goal of the ASC Student Supercomputer Challenge is to foster the next generation of young talent, to inspire exploration, innovation, and collaboration in supercomputing and AI. Your efforts in designing, building, tuning, and optimizing your HPC systems, benchmarks and real scientific applications with a 3 kilowatt power cap are truly inspirational."

About ASC

The ASC Student Supercomputer Challenge stands as the world's most extensive competition in student supercomputing, expertly organized and sponsored by the Asia Supercomputer Community with support from esteemed institutions and experts across Asia, Europe, and America. ASC's primary goals encompass fostering international exchange and training for budding supercomputing talents, enhancing applications and research capabilities in the field, propelling the advancement of supercomputing technologies, and stimulating technical and industrial innovation. Since its inception in 2012, the ASC Student Supercomputer Challenge has attracted close to 10,000 undergraduate participants hailing from all corners of the globe. Learn more about ASC at http://asc-events.org/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230518005351/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Scoring Big With Fans: Balchem Spotlights the Power of Vitamin K2 at FC Bayern Women’s Season Opener18.9.2025 14:33:00 CEST | Press release

Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health – and official partner of FC Bayern (FCB) Women’s football team - has launched its first ever direct-to-consumer initiative, showcasing the power of vitamin K2 to FCB fans. The company promoted its K2VITAL™ brand with an exhibition stand at the Allianz Arena in Munich, during the opening game of the Bundesliga (German football league) on 6 September. This initiative is part of Balchem’s latest marketing strategy, which aims to raise consumer awareness of the health benefits vitamin K2 has to offer, bridging the gap between B2B and B2C markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918950889/en/ Balchem Spotlights The Power of Vitamin K2 at FC Bayern Women’s Season Opener Co-Branded K2 Health Vitamins Hit the Pitch The opening event of the season provided a unique platform for Balchem to promote K2VITAL™, a patented, typ

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy18.9.2025 14:30:00 CEST | Press release

- CASGEVY is the first, and only, gene editing therapy approved for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD) in Europe -- Italy has the largest population of people living with TDT in Europe- Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with the Italian Medicines Agency (AIFA) for eligible transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). “Today is a turning point for eligible people in Italy living with transfusion-dependent beta thalassemia and sickle cell disease, two life-shortening diseases with limited treatment options,” said Ludovic Fenaux, Senior Vice President, Vertex International. “Italy has the largest TDT population in Europe, which underscores the importance of this agreement. We appreciate the collaboration with AIFA to recognize the value a one-time transformati

European DataWarehouse Appoints Nigel Batley as Executive Director of Its UK Subsidiary18.9.2025 12:41:00 CEST | Press release

European DataWarehouse Ltd. (EDW Ltd.) the UK subsidiary of European DataWarehouse GmbH, today announced the appointment of Nigel Batley as Executive Director. Mr. Batley succeeds Markus Schaber, who will retire from the role after serving as Executive Director since 2020. With nearly 40 years of experience in the financial services industry, Mr. Batley brings extensive expertise in asset-backed finance. He spent more than 30 years at HSBC, where he held senior positions including Global Head of Structured Finance, before taking on advisory and leadership roles in the securitisation market. Markus Schaber, outgoing Executive Director of EDW Ltd., will remain with the company as Senior Advisor. He commented: “It has been a privilege to lead European DataWarehouse in the UK and contribute to the development of greater transparency in European securitisation markets. I am confident that Nigel’s deep industry knowledge and leadership will strengthen EDW Ltd.’s mission and ensure we continu

Zycus Recognized as A Customers’ Choice in 2025 Gartner® Peer Insights™ “Voice of the Customer” for Source-to-Pay Suites18.9.2025 11:20:00 CEST | Press release

Zycus, a global leader in procurement and source-to-pay transformation, today announced it has been recognized as A Customers’ Choice in 2025 Gartner Peer Insights™ “Voice of the Customer”: Source-to-Pay Suites report. The Gartner Peer Insights report aggregates ratings and reviews from verified end users over an 18-month ending June 30, 2025. To qualify, vendors must have at least 20 eligible reviews and meet thresholds for capabilities and support. In the 2025 report, only eight vendors qualified, with Zycus placed in the Customers’ Choice quadrant — highlighting vendors rated above the market average for both Overall Experience and User Interest & Adoption. Recognition Backed by Customer Experience According to the report, Zycus achieved: 4.6 out of 5 Overall Rating, based on 67 peer reviews as of June 30, 2025. 95% willingness to recommend score – reflecting customer trust and satisfaction. Ratings across Product Capabilities, Sales Experience, Deployment, and Support, each above 4

Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer18.9.2025 11:00:00 CEST | Press release

Neumirna Therapeutics, a biotechnology company developing RNA-based therapies for neurological diseases, today announced the appointment of Ellen K. Donnelly, Ph.D. as Chief Executive Officer. Ellen brings more than 20 years of leadership in neuroscience and rare diseases, spanning both global pharmaceutical companies and innovative biotech firms. She joins Neumirna from her role as CEO of Abliva AB, recently acquired by Pharming Group, and has previously led Modus Therapeutics and Souvien Therapeutics. Earlier in her career, Ellen spent nearly a decade at Pfizer Inc., where she held leadership roles in neuroscience research, clinical operations, portfolio management, and strategy. She holds a Ph.D. in Pharmacology & Neuroscience from Yale University. "Ellen combines scientific expertise with proven leadership in both biotech and pharma," said Luis Pareras, Chairman of the Board at Neumirna. "The Board is confident that under her guidance, Neumirna will continue to translate our innova

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye